Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Classifica tra le azioni #27535
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Prezzo delle azioni
$0.0416118
Capitalizzazione di mercato
$32.25M
Variazione (1 giorno)
-1.67%
Variazione (1 anno)
-59.58%
Paese
AU
Scambia Neurizon Therapeutics Limited (NUZ)

Categoria

Storico del rendimento da dividendi per Neurizon Therapeutics Limited (NUZ)
Il rendimento da dividendi (TTM) di Neurizon Therapeutics Limited (simbolo azionario: NUZ) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Neurizon Therapeutics Limited (NUZ) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH